Article info
PDFClinical and epidemiological research
Concise report
Demyelinating events in rheumatoid arthritis after drug exposures
- Correspondence to Samy Suissa, Centre for Clinical Epidemiology, Jewish General Hospital – Lady Davis Institute, 3755 Cote Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada; samy.suissa{at}mcgill.ca
Citation
Demyelinating events in rheumatoid arthritis after drug exposures
Publication history
- Accepted June 27, 2009
- First published July 23, 2009.
Online issue publication
April 09, 2023
Article Versions
- Previous version (25 October 2017).
- Previous version (25 October 2017).
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions